Financing Receivables	6 Months Ended
Jul. 01, 2017
Notes To Financial Statements [Abstract]
Financing Receivables	Financing Receivables Long-term trade financing receivables of $190.8 million and $180.9 million at July 1, 2017 and December 31, 2016, respectively, are reported within Other Assets in the Condensed Consolidated Balance Sheets. Financing receivables and long-term financing receivables are predominantly related to certain security equipment leases with commercial businesses. Generally, the Company retains legal title to any equipment under lease and bears the right to repossess such equipment in an event of default. All financing receivables are interest bearing and the Company has not classified any financing receivables as held-for-sale. Interest income earned from financing receivables that are not delinquent is recorded on the effective interest method. The Company considers any financing receivable that has not been collected within 90 days of original billing date as past-due or delinquent. Additionally, the Company considers the credit quality of all past-due or delinquent financing receivables as non-performing. The Company has an accounts receivable sale program that expires on January 5, 2018. According to the terms of that program, the Company is required to sell certain of its trade accounts receivables at fair value to a wholly-owned, consolidated, bankruptcy-remote special purpose subsidiary (“BRS”). The BRS, in turn, must sell such receivables to a third-party financial institution (“Purchaser”) for cash and a deferred purchase price receivable. The Purchaser’s maximum cash investment in the receivables at any time is $100.0 million. The purpose of the program is to provide liquidity to the Company. The Company accounts for these transfers as sales under ASC 860, "Transfers and Servicing." Receivables are derecognized from the Company’s consolidated balance sheet when the BRS sells those receivables to the Purchaser. The Company has no retained interests in the transferred receivables, other than collection and administrative responsibilities and its right to the deferred purchase price receivable. At July 1, 2017, the Company did not record a servicing asset or liability related to its retained responsibility based on its assessment of the servicing fee, market values for similar transactions and its cost of servicing the receivables sold. At July 1, 2017 and December 31, 2016, $100.8 million and $100.5 million, respectively, of net receivables were derecognized. Gross receivables sold amounted to $549.3 million ($464.0 million, net) and $1,003.1 million ($852.9 million, net) for the three and six months ended July 1, 2017, respectively. These sales resulted in a pre-tax loss of $1.9 million and $3.3 million, respectively, and included servicing fees of $0.4 million and $0.6 million, respectively, for the three and six months ended July 1, 2017. Proceeds from transfers of receivables to the Purchaser totaled $444.1 million and $781.1 million for the three and six months ended July 1, 2017, respectively. Collections of previously sold receivables, including deferred purchase price receivables, and all fees, which are settled one month in arrears, resulted in payments to the Purchaser of $408.7 million and $781.1 million for the three and six months ended July 1, 2017, respectively. Gross receivables sold amounted to $488.8 million ($404.9 million, net) and $873.5 million ($746.2 million, net) for the three and six months ended July 2, 2016, respectively. These sales resulted in a pre-tax loss of $1.4 million and $2.4 million, respectively, and included servicing fees of $0.2 million and $0.4 million, respectively, for the three and six months ended July 2, 2016. Proceeds from transfers of receivables to the Purchaser totaled $400.0 million and $677.6 million, respectively, for the three and six months ended July 2, 2016. Collections of previously sold receivables, including deferred purchase price receivables, and all fees, which are settled one month in arrears, resulted in payments to the Purchaser of $383.4 million and $677.6 million, respectively, for the three and six months ended July 2, 2016. The Company’s risk of loss following the sale of the receivables is limited to the deferred purchase price receivable, which was $166.3 million at July 1, 2017 and $83.2 million at December 31, 2016. The deferred purchase price receivable will be repaid in cash as receivables are collected, generally within 30 days, and as such the carrying value of the receivable recorded approximates fair value. There were no delinquencies or credit losses for the three and six months ended July 1, 2017 and July 2, 2016. Cash inflows related to the deferred purchase price receivable totaled $158.5 million and $288.4 million for the three and six months ended July 1, 2017, respectively, and $128.7 million and $219.5 million for the three and six months ended July 2, 2016, respectively. All cash flows under the program are reported as a component of changes in working capital within operating activities in the Condensed Consolidated Statements of Cash Flows since all the cash from the Purchaser is either: 1) received upon the initial sale of the receivable or 2) from the ultimate collection of the underlying receivables and the underlying receivables are not subject to significant risks, other than credit risk, given their short-term nature.

Financing Receivables

Long-term trade financing receivables of $190.8 million and $180.9 million at July 1, 2017 and December 31, 2016, respectively, are reported within Other Assets in the Condensed Consolidated Balance Sheets. Financing receivables and long-term financing receivables are predominantly related to certain security equipment leases with commercial businesses. Generally, the Company retains legal title to any equipment under lease and bears the right to repossess such equipment in an event of default. All financing receivables are interest bearing and the Company has not classified any financing receivables as held-for-sale. Interest income earned from financing receivables that are not delinquent is recorded on the effective interest method. The Company considers any financing receivable that has not been collected within 90 days of original billing date as past-due or delinquent. Additionally, the Company considers the credit quality of all past-due or delinquent financing receivables as non-performing.

The Company has an accounts receivable sale program that expires on January 5, 2018. According to the terms of that program, the Company is required to sell certain of its trade accounts receivables at fair value to a wholly-owned, consolidated, bankruptcy-remote special purpose subsidiary (“BRS”). The BRS, in turn, must sell such receivables to a third-party financial institution (“Purchaser”) for cash and a deferred purchase price receivable. The Purchaser’s maximum cash investment in the receivables at any time is $100.0 million. The purpose of the program is to provide liquidity to the Company. The Company accounts for these transfers as sales under ASC 860, "Transfers and Servicing." Receivables are derecognized from the Company’s consolidated balance sheet when the BRS sells those receivables to the Purchaser. The Company has no retained interests in the transferred receivables, other than collection and administrative responsibilities and its right to the deferred purchase price receivable. At July 1, 2017, the Company did not record a servicing asset or liability related to its retained responsibility based on its assessment of the servicing fee, market values for similar transactions and its cost of servicing the receivables sold.

At July 1, 2017 and December 31, 2016, $100.8 million and $100.5 million, respectively, of net receivables were derecognized. Gross receivables sold amounted to $549.3 million ($464.0 million, net) and $1,003.1 million ($852.9 million, net) for the three and six months ended July 1, 2017, respectively. These sales resulted in a pre-tax loss of $1.9 million and $3.3 million, respectively, and included servicing fees of $0.4 million and $0.6 million, respectively, for the three and six months ended July 1, 2017. Proceeds from transfers of receivables to the Purchaser totaled $444.1 million and $781.1 million for the three and six months ended July 1, 2017, respectively. Collections of previously sold receivables, including deferred purchase price receivables, and all fees, which are settled one month in arrears, resulted in payments to the Purchaser of $408.7 million and $781.1 million for the three and six months ended July 1, 2017, respectively.

Gross receivables sold amounted to $488.8 million ($404.9 million, net) and $873.5 million ($746.2 million, net) for the three and six months ended July 2, 2016, respectively. These sales resulted in a pre-tax loss of $1.4 million and $2.4 million, respectively, and included servicing fees of $0.2 million and $0.4 million, respectively, for the three and six months ended July 2, 2016. Proceeds from transfers of receivables to the Purchaser totaled $400.0 million and $677.6 million, respectively, for the three and six months ended July 2, 2016. Collections of previously sold receivables, including deferred purchase price receivables, and all fees, which are settled one month in arrears, resulted in payments to the Purchaser of $383.4 million and $677.6 million, respectively, for the three and six months ended July 2, 2016.

The Company’s risk of loss following the sale of the receivables is limited to the deferred purchase price receivable, which was $166.3 million at July 1, 2017 and $83.2 million at December 31, 2016. The deferred purchase price receivable will be repaid in cash as receivables are collected, generally within 30 days, and as such the carrying value of the receivable recorded approximates fair value. There were no delinquencies or credit losses for the three and six months ended July 1, 2017 and July 2, 2016. Cash inflows related to the deferred purchase price receivable totaled $158.5 million and $288.4 million for the three and six months ended July 1, 2017, respectively, and $128.7 million and $219.5 million for the three and six months ended July 2, 2016, respectively. All cash flows under the program are reported as a component of changes in working capital within operating activities in the Condensed Consolidated Statements of Cash Flows since all the cash from the Purchaser is either: 1) received upon the initial sale of the receivable or 2) from the ultimate collection of the underlying receivables and the underlying receivables are not subject to significant risks, other than credit risk, given their short-term nature.